Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion type Assertion NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_head.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion evidence source_evidence_literature NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion SIO_000772 20609468 NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion wasDerivedFrom gad-20150221 NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion wasGeneratedBy ECO_0000203 NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.